Global In-vitro Colorectal Cancer Screening Tests Market 2019-2023
SKU ID : TNV-13792964 | Publishing Date : 07-Jan-2019 | No. of pages : 112
Detailed TOC of Global In-vitro Colorectal Cancer Screening Tests Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Hospitals - Market size and forecast 2018-2023
• Clinical diagnostic laboratories - Market size and forecast 2018-2023
• Others - Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas - Market size and forecast 2018-2023
• EMEA - Market size and forecast 2018-2023
• APAC - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• Danaher
• QIAGEN
• Quest Diagnostics
• Siemens
PART 13: APPENDIX
• Research methodology
• List of abbreviations
Exhibit 01: Years in consideration
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: End-user - Market share 2018-2023 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Hospitals - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Hospitals - Year-over-year growth 2019-2023 (%)
Exhibit 22: Clinical diagnostic laboratories - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Clinical diagnostic laboratories - Year-over-year growth 2019-2023 (%)
Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Others - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 32: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 34: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Decision framework
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Abbott - Vendor overview
Exhibit 46: Abbott - Business segments
Exhibit 47: Abbott - Organizational developments
Exhibit 48: Abbott - Geographic focus
Exhibit 49: Abbott - Segment focus
Exhibit 50: Abbott - Key offerings
Exhibit 51: Danaher - Vendor overview
Exhibit 52: Danaher - Business segments
Exhibit 53: Danaher - Organizational developments
Exhibit 54: Danaher - Geographic focus
Exhibit 55: Danaher - Segment focus
Exhibit 56: Danaher - Key offerings
Exhibit 57: QIAGEN - Vendor overview
Exhibit 58: QIAGEN - Product segments
Exhibit 59: QIAGEN - Organizational developments
Exhibit 60: QIAGEN - Geographic focus
Exhibit 61: QIAGEN - Segment focus
Exhibit 62: QIAGEN - Key offerings
Exhibit 63: Quest Diagnostics - Vendor overview
Exhibit 64: Quest Diagnostics - Business segments
Exhibit 65: Quest Diagnostics - Organizational developments
Exhibit 66: Quest Diagnostics - Segment focus
Exhibit 67: Quest Diagnostics - Key offerings
Exhibit 68: Siemens - Vendor overview
Exhibit 69: Siemens - Business segments
Exhibit 70: Siemens - Organizational developments
Exhibit 71: Siemens - Geographic focus
Exhibit 72: Siemens - Segment focus
Exhibit 73: Siemens - Key offerings
Exhibit 74: Validation techniques employed for market sizing
Exhibit 75: List of abbreviations
Keyplayers in Global In-vitro Colorectal Cancer Screening Tests Market 2019-2023
AbbottDanaher
QIAGEN
Quest Diagnostics
Siemens